EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors

Tomoshige Shimizu iD, Tomoyasu Jo iD, Noriyoshi Yoshinaga iD, Takashi Sakamoto, Hiroyuki Matsui, Toshio Kitawaki, Junya Kanda, Momoko Nishikori, Kouhei Yamashita, Miki Nagao, Akifumi Takaori-Kondo, Yasuyuki Arai iD

Transfusion · 2026

DOI: 10.1111/trf.70286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2026. Verfasst von Tomoshige Shimizu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Kyoto University Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Filgrastim, Polyethylene Glycols, Hematopoietic Stem Cell Mobilization, Peripheral Blood Stem Cells. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Granulocyte colony‐stimulating factor (G‐CSF)‐based mobilization is essential for peripheral blood stem cell (PBSC) collection for allogeneic transplantation. Conventional daily G‐CSF requires repeated dosing and dose adjustment and often necessitates leukapheresis over multiple consecutive days, increasing donor burden. Single‐dose pegfilgrastim has emerged as an alternative; however, real‐world data on its impact on CD34 + cell collection in healthy donors remain limited. Study Design and Methods Healthy related or unrelated donors who received either a single dose of pegfilgrastim or daily filgrastim and subsequently underwent PBSC collection at Kyoto University Hospital between July 2014 and September 2025 were included. CD34 + cell harvest outcomes and donor burden were compared.

Results

A total of 39 donors were analyzed (20 pegfilgrastim, 19 filgrastim), with comparable baseline characteristics. At the start of leukapheresis, peripheral blood white blood cell counts were significantly higher in the pegfilgrastim group. Pegfilgrastim achieved greater total CD34 + cell yield (median 398.0 × 10 6 vs. 302.4 × 10 6 cells, p = .025) and higher yields per 10 L of processed blood (median 407.8 × 10 6 vs. 302.4 × 10 6 cells, p = .032). Single‐session leukapheresis was more frequent with pegfilgrastim (95.0% vs. 63.2%, p = .002), and the estimated processing time required to collect 2 × 10 6 /kg CD34 + cells was shorter (median 62.7 vs. 111.1 min, p = .040). No severe adverse events were observed.

Discussion

These findings suggest that single‐dose pegfilgrastim enables more efficient PBSC collection with reduced donor burden and may represent a practical mobilization strategy in healthy allogeneic donors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FilgrastimPolyethylene GlycolsHematopoietic Stem Cell MobilizationPeripheral Blood Stem CellsPeripheral Blood Stem Cell TransplantationHumansFemaleAdultMaleMiddle AgedAntigens, CD34LeukapheresisYoung AdultBlood DonorsTransplantation, Homologous

Stichwörter der Autor:innen

CD34+ yieldPBSC mobilizationallogeneic donorsfilgrastimpegfilgrastim

Substanzen

FilgrastimpegfilgrastimPolyethylene GlycolsAntigens, CD34

Autor:innen und Institutionen

  • Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Department of Cytotherapy, Kyoto University Hospital, Kyoto, Japan.
  • Center for Research and Application of Cellular Therapy, Kyoto University Hospital, Kyoto, Japan.
  • Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

ORCID-Profile: Tomoshige Shimizu, Tomoyasu Jo, Noriyoshi Yoshinaga, Yasuyuki Arai

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Shimizu, T., Jo, T., Yoshinaga, N., Sakamoto, T., Matsui, H., Kitawaki, T., Kanda, J., Nishikori, M., Yamashita, K., Nagao, M., Takaori-Kondo, A., & Arai, Y. (2026). Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors. Transfusion. https://doi.org/10.1111/trf.70286

Vancouver

Shimizu T, Jo T, Yoshinaga N, Sakamoto T, Matsui H, Kitawaki T, et al. Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors. Transfusion. 2026. doi:10.1111/trf.70286

BibTeX
@article{Shimizu2026,
  author = {Shimizu, Tomoshige and Jo, Tomoyasu and Yoshinaga, Noriyoshi and Sakamoto, Takashi and Matsui, Hiroyuki and Kitawaki, Toshio and Kanda, Junya and Nishikori, Momoko and Yamashita, Kouhei and Nagao, Miki and Takaori-Kondo, Akifumi and Arai, Yasuyuki},
  title = {Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.70286}
}
Kostenlos starten →